Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 7000
TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: 3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCyclin-dependent kinase 9(Human)
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50: 10nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCyclin-dependent kinase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: 94nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 alpha(Human)
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50: 99nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 alpha(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: 160nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCyclin-dependent kinase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: 168nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCyclin-dependent kinase 3(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: 219nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50: 857nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: 903nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCyclin-dependent kinase 2(Human)
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50: 913nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCyclin-dependent kinase 5(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: 1.08E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCyclin-dependent kinase 5(Human)
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50: 1.34E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCyclin-dependent kinase 3(Human)
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50: 1.45E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCyclin-dependent kinase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50: 1.88E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 receptor-associated kinase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50: 5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetInterleukin-1 receptor-associated kinase 1(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: 5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCyclin-dependent kinase 7(Human)
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50: 5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCyclin-dependent kinase 7(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: 5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCyclin-dependent kinase 6(Human)
Astrazeneca

US Patent
LigandPNGBDBM164884(US9067888, 34)
Affinity DataIC50: 5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCyclin-dependent kinase 6(Human)
Astrazeneca

US Patent
LigandPNGBDBM164883(US9067888, 33)
Affinity DataIC50: 5.00E+3nMpH: 7.5Assay Description:In vitro kinase assay analysis may be performed using standard techniques described in the art. These techniques are also used by commercial services...More data for this Ligand-Target Pair
In DepthDetails
US Patent